Seb Walsh
@seb_walsh
Public Heath Doctor and NIHR Doctoral Fellow researching population approaches to dementia risk reduction @CamPubHealth. Views own, retweets not endorsements.
ID:580946268
15-05-2012 12:56:02
5,1K Tweets
867 Followers
924 Following
Follow People
Robert Howard
UCL old age psychiatrist | Improving dementia and mental health treatment | Independent trials | Layla | Talk to me about academic careers
David Oliver
NHS Dr 35 y. Covid wards++ Gov, policy, academic, officer roles. Byline: @BMJ_latest. Columns: health press, papers. @mjauk. Manc-in-South. MCFC. Craic. Schlock
greg fell FFPH
DPH @Sheffcouncil. President @ADPHUK. co investigator @sipherc. member UKNSC. Tweets = my view. RTs= someone else's view. Death metal enthusiast.
Simon Mead
Prions dementia climbing running dog walking Dad & husband. National Prion Clinic UCLH. Deputy Director @MRC_Prion @UCL NIHR Senior Investigator
John Burn-Murdoch
Columnist and chief data reporter @FinancialTimes | Stories, stats & scatterplots | Senior fellow @LSEdataScience | [email protected]
📺 Watch me set out some key facts about #dementia and the inequalities that exist in dementia services:
Alzheimer's Society APPG on Dementia Alzheimer's Research UK Dementia UK Dementia United Springboard Oldham Dementia Carers Group
Ben Spencer Ash Paul Simon Mead Andrew Kiselica, PhD, ABPP CottageCare Lon S. Schneider, MD Jeff Browndyke Andrew Lees Madhav Thambisetty Timothy Daly, PhD Nicolas Villain Eric Widera, MD Jason Cohen shibley Seb Walsh Michael Schöll Vincent Planche Stefano L. Sensi Alberto J Espay Kasper Planeta Kepp Gill Livingston Ryan Townley Jesse F Ballenger (mastodon.world/@jfballenger) Jason Karlawish James Rupert Fletcher Adam M. Brickman Dr. Jennifer Manly Sarah Ackley, PhD FORTUNE TIME Erin Prater, M.A.², CHES® TIME Financial Times Hannah Kuchler CTAD NIH Alzheimer's Association Howard Gleckman American Geriatrics Society Kathy Liu Richard Merrick Nancy Lundebjerg (she/her/hers) Nathaniel Chin U.S. FDA EU Medicines Agency CDA-AMC NICE Dana P Goldman, PhD NHS England Nick Triggle It’s just hard to escape from the enormous importance of being realistic about efficacy and risks with these drugs in the context of how we prioritise them and how we shape the expectations of patients and families, most of whom are going to be ineligible anyway.
From steven hackett board meeting. Dry and hugely important, the final version of this oversight & assessment framework will be a litmus test of whether ICSs will be freed to pursue and deliver the principles for which they were created england.nhs.uk/long-read/upda…
Can football organisations provide culturally appropriate post-diagnostic dementia support?🏈🧠🤔
You are invited to a Leeds Beckett Centre for Dementia Research Public Lecture: Leeds, 13th June, 11am with the incredible Marie Poole 😍
To register, and further info: shorturl.at/lmuW8
One more study supporting that 5-8% of people with #Alzheimer ’s disease would be eligible for #lecanemab neurology.org/doi/10.1212/WN…
Thrilled to see the spotlight on my research during #DementiaActionWeek ! It's incredibly validating to have my work showcased in such a crucial yet under-researched area & this recognition highlights the potential impact on patients NTU Psychology NTU Research NTU Doctoral School
Soaring dementia care costs reach £42 billion in UK and families bear the brunt.
Head to our website to find out more about the staggering financial impact of dementia in the UK alzheimers.org.uk/news/2024-05-1… #DementiaActionWeek
Important long read in BMJ from Dr Lucinda Hiam Sir Michael Marmot on tackling social determinants of health to sustain NHS
“Response is we cannot afford such action - we argue, we cannot afford inaction”
We have the evidence but need cross-party political action
bmj.com/content/385/bm…